Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BRI Biopharmaceutical Research
Vancouver, British Columbia, Canadacontractlaboratory.com ↗
- Ownership
- Private
- Employees
- ~2
- Development stage
- Other
01
Overview
BRI Biopharmaceutical Research was an analytical and bioanalytical CRO providing specialized services in discovery, preclinical, and clinical development for pharmaceutical and biotechnology companies. The company supported IND and NDA-enabling studies with expertise in quantitative assays for small molecules, metabolites, chemical biomarkers, as well as large molecules using immunochemical ELISA and cell-based assays. It also performed CMC studies including HPLC, GC/Headspace assay, GC/MS assay of drug substances/products[3][7].
The company was acquired by Frontage Laboratories on December 19, 2019[3].
No proprietary clinical results or pipeline exist as it did not develop its own therapeutics.
It held certifications such as GMP/GLP establishment license from Health Canada; licenses for controlled substances; CCAC/AAALAC accreditation for animal care; CFIA Animal Pathogen Import Permit; Health Canada Human Pathogen Importation Permit[7].
Its annual revenue was estimated at $2 million with approximately two employees at the time of reporting[4].
Headquarters were located in Vancouver, British Columbia.
- Modalities
- Small moleculeLarge molecule (including biologics)Protein (via immunochemical and cell-based assays)Peptides (as part of analytical services)
- Industry
- Contract Research Organization
Beyond the preview
Go deeper on BRI Biopharmaceutical Research.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BRI Biopharmaceutical Research.